Amide Technologies

Amide Technologies

Accelerating drug development with rapid peptide synthesis and high-speed delivery.

HQ location
Cambridge, United States
Launch date
Employees
Enterprise value
$30—45m
  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

€0.0

round
investor

€0.0

Valuation: €0.0

round
*

$7.5m

Series A
Total Funding000k
Notes (0)
More about Amide Technologies
Made with AI
Edit

AmideTech operates in the pharmaceutical and biotechnology sectors, specializing in the synthesis of complex peptides and proteins. The company serves pharmaceutical companies, research institutions, and biotech firms that require high-quality peptides for drug discovery and development. AmideTech's business model focuses on providing custom peptide synthesis services, including the production of long polyamides and full-length proteins. The company differentiates itself by accepting challenging orders that other vendors refuse and delivering them in less than a week, thus accelerating the drug development process. Revenue is generated through the sale of these specialized peptide synthesis services. AmideTech's competitive advantage lies in its ability to produce significantly longer peptides and its commitment to high-speed delivery, which is critical in the fast-paced world of drug discovery. The company also emphasizes a collaborative and transparent work culture, attracting highly motivated scientists and engineers to its team.

Keywords: peptide synthesis, drug development, biotechnology, pharmaceutical, custom peptides, rapid delivery, polyamides, protein ligation, research institutions, biotech firms.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo